How should I acutely manage a patient with suspected inflammatory bowel disease and a fecal calprotectin level of 2100 µg/g?

Acute Management of Suspected IBD with Fecal Calprotectin 2100 µg/g

A fecal calprotectin of 2100 µg/g in a patient with suspected inflammatory bowel disease indicates severe active intestinal inflammation and requires immediate hospitalization, urgent endoscopic evaluation with biopsies, cross-sectional imaging to exclude complications, and initiation of intravenous corticosteroids without delay while excluding infection.

Immediate Assessment and Stabilization

Your patient requires prompt hospitalization given the markedly elevated calprotectin suggesting severe disease activity 1. The initial management must include:

Supportive Care

• Intravenous fluid resuscitation - correct dehydration and electrolyte abnormalities
• Nutritional assessment - check albumin, consider nutritional support
• Prophylactic anticoagulation - all hospitalized IBD patients require venous thromboembolism prophylaxis 1
• Monitor vital signs - temperature >37.8°C, heart rate >90 bpm, hemoglobin <105 g/L indicate severe disease 2

Rule Out Infection FIRST

Critical pitfall: Never start immunosuppression before excluding infection 3, 1.

• Stool cultures including C. difficile toxin (IBD patients have increased CDI risk) 3
• Blood cultures if febrile
• Consider CMV testing if severely ill (serum PCR and plan for tissue biopsies)
• Screen for tuberculosis, hepatitis B/C, HIV, VZV before starting biologics 2

Diagnostic Workup

Cross-Sectional Imaging - Do This Urgently

Contrast-enhanced CT scan is the key emergency study to exclude 4:

• Intestinal perforation
• Intra-abdominal abscess
• Strictures causing obstruction
• Toxic megacolon
• Source of bleeding

CT is preferred over plain abdominal X-ray when severe complications are suspected 2, 4.

Endoscopic Evaluation

Flexible sigmoidoscopy or colonoscopy with biopsies should be performed urgently 2, 1:

• Confirms diagnosis and disease extent
• Assesses severity (deep ulceration predicts poor outcome)
• Obtains tissue for histology and CMV immunohistochemistry
• Identifies bleeding source if present

With a calprotectin of 2100 µg/g, you have >90% probability of finding moderate to severe endoscopic inflammation 5, 6. This level far exceeds the 150-250 µg/g thresholds used to "rule in" active disease.

Initial Medical Treatment

If Ulcerative Colitis Pattern (≥6 bloody stools/day with systemic toxicity)

Start IV corticosteroids immediately - do not delay for stool culture results 2:

• IV methylprednisolone 60 mg daily OR
• IV hydrocortisone 100 mg every 6 hours

Assess response at 72 hours using the Travis criteria 2:

• If >8 bowel movements/day OR 3-8 movements with CRP >45 mg/L = 85% chance of steroid failure
• If failing steroids: initiate rescue therapy (infliximab or cyclosporine) or proceed to colectomy
• Surgical consultation should occur early, not after medical failure 1

If Crohn's Disease Pattern

For moderate to severe symptoms with calprotectin >150 µg/g (yours is 2100), the AGA recommends using the elevated biomarker to inform treatment adjustment and avoid routine endoscopy solely for confirming inflammation 5. However, in the acute/hospitalized setting, endoscopy is still warranted to:

• Establish the diagnosis in a new patient
• Assess for complications (strictures, fistulas, abscesses)
• Rule out CMV or other infections

Treatment options:

• IV corticosteroids (methylprednisolone 60-80 mg daily) for moderate-severe disease 7
• Early advanced therapy (biologics) should be strongly considered rather than relying on repeated steroid courses 7
• If obstruction present: IV steroids only if active inflammation confirmed; otherwise surgical consultation 1
• If abscess present: drainage (if >3 cm) + antibiotics + decision on medical vs surgical management 1

Monitoring During Hospitalization

• Daily senior gastroenterology review 2
• Daily labs: CBC, CRP, electrolytes, albumin
• Repeat imaging if worsening abdominal pain, distension, or systemic toxicity
• Stool frequency and character - document daily
• Surgical review if severe abdominal pain, toxic megacolon, perforation suspected, or failure to respond to medical therapy within 72 hours 2

Common Pitfalls to Avoid

1. Do not withhold treatment waiting for stool cultures - start IV steroids immediately in severe colitis 2
2. Do not use metronidazole for C. difficile in IBD patients - use fidaxomicin or vancomycin 3
3. Do not stop immunosuppression if concurrent CDI diagnosed - treat both simultaneously 3
4. Do not delay surgical consultation - early involvement improves outcomes 1
5. Do not use opiates for pain control - risk of toxic megacolon 8

Disposition Planning

Stability must be achieved before discharge 1:

• <4 bowel movements/day for at least 2 consecutive days
• No rectal bleeding
• Normalized or improving inflammatory markers
• Clear transition plan with outpatient gastroenterology follow-up within 1-2 weeks
• If started on biologics, ensure loading doses completed
• If on oral steroids, provide clear tapering schedule

The extraordinarily high calprotectin of 2100 µg/g indicates this patient has severe active inflammation requiring aggressive inpatient management with close monitoring for complications and potential need for rescue therapy or surgery.